Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: A retrospective multicenter study of the Austrian Study Group on Urologic Oncology
Open Access
- 1 December 1997
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (12), 1229-1234
- https://doi.org/10.1023/a:1008286305312
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumorsWorld Journal of Urology, 1996
- High-dose chemotherapy in germ-cell tumorsAnnals of Oncology, 1996
- High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.Journal of Clinical Oncology, 1996
- Antitumor activity of paclitaxel after failure of high-dose chemotherapy in a patient with late relapse of a non-seminomatous germ cell tumorAnti-Cancer Drugs, 1996
- Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerAnnals of Oncology, 1996
- Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Surgical salvage of chemorefractory germ cell tumors.Journal of Clinical Oncology, 1993
- Chronic oral etoposideCancer, 1991
- VP-16–213 salvage therapy for refractory germinal neoplasmsCancer, 1980